Immunome (IMNM) News
NASDAQ: IMNMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
IMNM news summary
We found 6 recent headlines mentioning Immunome (IMNM): 0 in the past week and 5 in the past 30 days, most often from Nasdaq, Seeking Alpha, Business Wire. IMNM is making an outsized move today, down 5.54% at $15.69, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Immunome, Inc. Reports Third Quarter 2026 Financial Results and Provides Business Update", was published by Nasdaq on Nov 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Immunome headlines
- Immunome, Inc. Reports Third Quarter 2026 Financial Results and Provides Business UpdateImmunome, Inc. reported its financial results for the third quarter ended September 30, 2026. As of September 30, 2026, cash, cash equivalents and marketable securities totaled $461.6 million, which…NasdaqIMNM, BF.A
- Immunome GAAP EPS of -$0.76 misses by $0.13Seeking Alpha
- Immunome Reports Third Quarter 2026 Financial Results and Provides Business UpdateBOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class cancer therapies, today announced…Business Wire
- Immunome stock may move 9.4% on earnings releaseInvesting.com
- 4 Biotech Stocks Likely to Outpace Q3 Earnings EstimatesFour biotech stocks, including TG Therapeutics and Immunome, show positive Earnings ESPs and favorable Zacks Ranks, positioning them for potential third-quarter earnings beats.NasdaqTGTX, RGNX, IMNM, PMN
- William Blair Initiates Coverage of Immunome at OutperformFintel reports that on October 16, 2026, William Blair initiated coverage of Immunome (NASDAQCM:IMNM) with a Outperform recommendation. Prior to this rating action, the stock closed at $17.40 on…Nasdaq